| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 03.5.2024 | 13:30 | GLOBE | Ocugen to Host Conference Call on Tuesday, May 14 at 8:30.. |
| 02.5.2024 | 13:15 | GLOBE | Ocugen Announces CSO to Present on Modifier Gene Therapy at.. |
| 29.4.2024 | 12:45 | GLOBE | Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data.. |
| 26.4.2024 | 15:05 | GLOBE | UPDATE -- Ocugen to Present on Modifier Gene Therapy.. |
| 26.4.2024 | 12:30 | GLOBE | Ocugen to Present on Modifier Gene Therapy Platform at.. |
| 19.4.2024 | 13:13 | GLOBE | Ocugen Announces Dosing Completion of Subjects with.. |
| 12.4.2024 | 13:30 | GLOBE | Ocugen to Participate in Fireside Chat at the Emerging.. |
| 10.4.2024 | 13:02 | GLOBE | Ocugen, Inc. Announces Positive Scientific Advice from the.. |
| 08.4.2024 | 12:30 | GLOBE | Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment.. |
| 05.4.2024 | 13:02 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 02.4.2024 | 14:00 | GLOBE | Ocugen Provides Business Update with Certain Financials for.. |
| 02.4.2024 | 00:08 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 01.4.2024 | 23:43 | GLOBE | Ocugen to Host Conference Call on Tuesday, April 2 at 8:30.. |
| 18.3.2024 | 11:30 | GLOBE | Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical.. |
| 13.3.2024 | 13:00 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 06.3.2024 | 13:30 | GLOBE | Ocugen to Present at Investing in Cures Summit |
| 28.2.2024 | 14:00 | GLOBE | Ocugen Clinical Showcase Webcast Now Available |
| 26.2.2024 | 14:30 | GLOBE | Ocugen Chairman and CEO to present at Abu Dhabi Family.. |
| 22.2.2024 | 22:05 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 21.2.2024 | 22:05 | GLOBE | Ocugen to Present at 2024 BIO CEO & Investor Conference |
| 21.2.2024 | 17:22 | EDGAR2 | Form 8-K - Current report |
| 14.2.2024 | 13:30 | GLOBE | Ocugen to Host Clinical Showcase in New York City.. |
| 31.1.2024 | 14:00 | GLOBE | Ocugen to Present at Pharma Market Research Conference |
| 16.1.2024 | 13:30 | GLOBE | Ocugen, Inc. Announces Bob Smith Joins Business Advisory.. |
| 08.1.2024 | 12:05 | EDGAR2 | Form 8-K - Current report |
| 05.1.2024 | 22:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.1.2024 | 22:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04.1.2024 | 23:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 04.1.2024 | 23:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 22.12.2023 | 21:09 | EDGAR2 | Form 8-K - Current report |
| 21.12.2023 | 12:30 | GLOBE | Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier.. |
| 19.12.2023 | 13:30 | GLOBE | Ocugen Announces OCU400 Receives Regenerative Medicine.. |
| 13.12.2023 | 13:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
| 29.11.2023 | 13:30 | GLOBE | Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’.. |
| 10.11.2023 | 13:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
| 09.11.2023 | 14:02 | EDGAR2 | Form 8-K - Current report |
| 09.11.2023 | 13:02 | EDGAR2 | Form 8-K - Current report |
| 09.11.2023 | 12:30 | GLOBE | Ocugen Provides Business Update with Third Quarter 2023.. |
| 09.11.2023 | 12:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 07.11.2023 | 13:45 | GLOBE | Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic.. |
| 02.11.2023 | 12:30 | GLOBE | Ocugen to Host Conference Call on Thursday, November 9 at.. |
| 10.10.2023 | 15:05 | EDGAR2 | Form 8-K - Current report |
| 10.10.2023 | 12:30 | GLOBE | Ocugen Mucosal Vaccine Candidate OCU500 Selected by.. |
| 04.10.2023 | 13:00 | GLOBE | Ocugen to Present at the 2023 Cell & Gene Meeting on the.. |
| 29.9.2023 | 13:30 | GLOBE | Ocugen CSO to Participate in 4th Annual Gene Therapy for.. |
| 28.9.2023 | 01:30 | GLOBE | Ocugen to Participate in Fireside Chat at Chardan’s 7th.. |
| 21.9.2023 | 13:30 | GLOBE | Ocugen, Inc. Announces Connie Collingsworth Joins Business.. |
| 20.9.2023 | 14:00 | GLOBE | Ocugen to Participate in Panel at Cantor Fitzgerald Global.. |
| 19.9.2023 | 22:54 | EDGAR2 | Form 8-K - Current report |
| 19.9.2023 | 22:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
